Further understanding of these interactions apart from the hormonal milieu of pregnancy will provide additional insight into the impact of PRL on increased breast cancer risk in premenopausal women and postmenopausal women treated with estrogen-progesterone MHT (107, 162, 182). The gene discussed is PRL; the disease is breast cancer.